GLP-1 medicines for weight management, explained

What GLP-1 actually is

GLP-1 — glucagon-like peptide-1 — is a hormone your gut releases after you eat. It does several things at once: it prompts the pancreas to release insulin when blood glucose is high, slows the rate at which the stomach empties, and signals to the brain that you have eaten enough.

The medicines used in weight management are engineered versions of that signal, modified so they last days rather than minutes. The result is a longer, steadier version of the fullness signal your body already produces.

Why appetite falls

Two mechanisms overlap. Food physically leaves the stomach more slowly, so fullness lasts longer after a meal. And receptors in the appetite centres of the brain are stimulated directly, which reduces the background drive to eat between meals — what many people describe as the constant mental chatter about food going quiet.

That second effect is the one people find most striking, and it is the one that makes habit change genuinely easier for a period.

Single, dual and triple agonists

The first generation acted on the GLP-1 receptor alone. Newer medicines add a second target, GIP, another gut hormone involved in insulin response and fat metabolism — acting on both produces greater average weight loss in trials than GLP-1 alone.

Compounds acting on a third receptor, glucagon, are in clinical development. Glucagon receptor activity is intended to raise energy expenditure as well as reduce intake. These triple agonists are investigational: they are not licensed by the MHRA or any other regulator, and cannot lawfully be supplied for human use in the UK.

What the numbers look like

Published trials of licensed dual agonists report average total body weight reduction in the region of 15 to 21 per cent over 72 weeks at higher doses, alongside lifestyle support. Averages hide a wide spread — some people lose considerably more, some considerably less, and a minority respond poorly.

The part that gets skipped

Reduced appetite makes it very easy to eat far too little protein. Weight lost without adequate protein and resistance training contains a greater proportion of lean tissue, which lowers resting metabolic rate and makes regain easier later. This is the most common avoidable mistake in the whole process.

The second is treating the medicine as the plan. Appetite returns when treatment stops. Whatever habits exist at that point are what determine the outcome.